A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.
The best Bull and Bear pitches based on recency and number of recommendations.
With European approval, news of a marketing partner will boost the price up.
Even some fools agree this OREX is not the king of Biotech, but its losses are declining. The lawsuit is a big negative if they lose so they have to really pull a rabbit out of their hat.
Read the most recent pitches from players about OREX.
Recs
mario60045
(< 20)
Submitted: 12/1/2015 11:02:48 PM :
Start Price:
$23.10
NASDAQ OTC:OREX Score:
-201.24
With European approval, news of a marketing partner will boost the price up.
Recs
chris293
(40.78)
Submitted: 5/20/2015 11:47:44 PM :
Start Price:
$50.80
NASDAQ OTC:OREX Score:
+202.71
Even some fools agree this OREX is not the king of Biotech, but its losses are declining. The lawsuit is a big negative if they lose so they have to really pull a rabbit out of their hat.
Recs
rknapton
(29.15)
Submitted: 8/22/2013 4:48:21 PM :
Start Price:
$69.60
NASDAQ OTC:OREX Score:
+255.39
Short. Trading at 200x sales. Massive losses and selling tons of stock.
Find the members with the highest scoring picks in OREX.
qubit15 (24.44) Score: +531.60
The Score Leader is the player with the highest score across all their picks in OREX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| qubit15 | 24.44 | 1/21/2009 |
|
NS | $43.50 | -99.49% | +432.12% | +531.60 | 0 Comment | |
| vulturecapitol | < 20 | 1/12/2009 |
|
1Y | $50.40 | -99.56% | +387.85% | +487.41 | 0 Comment | |
| JeffBone | 83.83 | 12/8/2008 |
|
NS | $45.10 | -99.51% | +381.94% | +481.44 | 0 Comment | |
| shephunts | 28.75 | 7/1/2009 |
|
5Y | $52.30 | -99.57% | +363.42% | +462.99 | 0 Comment | |
| gmxBatteringRam | 27.75 | 6/5/2009 |
|
3W | $42.00 | -99.47% | +355.92% | +455.39 | 0 Comment | |
| BASSTRAX | 62.99 | 9/9/2009 |
|
3Y | $85.30 | -99.74% | +316.00% | +415.74 | 0 Comment | |
| l00weredblaze | < 20 |
|
|
5Y | $90.40 | -99.75% | +313.88% | +413.63 | 0 Comment | |
| anticitrademix2 | < 20 | 11/2/2009 |
|
5Y | $68.20 | -99.67% | +308.99% | +408.66 | 0 Comment | |
| anticitrademix | < 20 | 11/2/2009 |
|
5Y | $68.20 | -99.67% | +308.99% | +408.66 | 0 Comment | |
| longtermgrowth09 | 51.91 | 12/17/2009 |
|
5Y | $76.20 | -99.71% | +284.65% | +384.35 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
